Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience-Reference-Cited by-同舟云学术

Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience

Published:2021-11 Issue:1 Volume:40 Page:32-40
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Massaro Fulvio¹²^ORCID,Pavone Vincenzo³,Stefani Piero Maria⁴,Botto Barbara⁵,Pulsoni Alessandro⁶,Patti Caterina⁷,Cantonetti Maria⁸,Visentin Andrea⁹^ORCID,Scalzulli Potito Rosario¹⁰,Rossi Andrea¹¹,Galimberti Sara¹²,Cimminiello Michele¹³,Gini Guido¹⁴,Musso Maurizio¹⁵,Sorio Marco¹⁶,Arcari Annalisa¹⁷,Zilioli Vittorio Ruggero¹⁸,Luppi Mario¹⁹,Mannina Donato²⁰,Fabbri Alberto²¹,Pietrantuono Giuseppe²²,Annibali Ombretta²³^ORCID,Tafuri Agostino²⁴,Prete Eleonora³,Mulè Antonino⁷,Barbolini Elisa²⁵,Marcheselli Luigi²⁶,Luminari Stefano²,Merli Francesco²

Affiliation:

1. PhD Program in Clinical and Experimental Medicine University of Modena and Reggio Emilia Modena Italy

2. Hematology Unit Azienda Unità Sanitaria Locale‐IRCCS di Reggio Emilia Reggio Emilia Italy

3. Department of Hematology and Bone Marrow Transplant Hospital Card. G. Panico Tricase Italy

4. Hematology Unit General Hospital Ca' Foncello Treviso Italy

5. Division of Hematology Città della Salute e della Scienza Hospital and University Torino Italy

6. Department of Translational and Precision Medicine Sapienza University Rome Italy

7. Division of Onco‐Hematology Azienda Villa Sofia‐Cervello Palermo Italy

8. Unit of Lymphoproliferative Disorders Policlinico Tor Vergata Rome Italy

9. Hematology and Clinical Immunology Unit Department of Medicine (DIMED) University of Padua Padua Italy

10. Department of Hematology Casa Sollievo della Sofferenza San Giovanni Rotondo Italy

11. Hematology Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo Italy

12. Division of Hematology Department of Clinical and Experimental Medicine University of Pisa Italy

13. Hematology San Carlo Hospital Potenza Italy

14. Division of Hematology Azienda Ospedaliera Universitaria Ospedali Riuniti Ancona Italy

15. Department of Oncology Hematology and BMT Unit Casa di Cura La Maddalena Palermo Italy

16. Department of Clinical and Experimental Medicine Hematology and Bone Marrow Transplant Unit University of Verona Verona Italy

17. Hematology Unit Ospedale Guglielmo da Saliceto Piacenza Italy

18. Division of Hematology ASST Grande Ospedale Metropolitano Niguarda Milano Italy

19. Department of Medical and Surgical Sciences University of Modena and Reggio Emilia Modena Italy

20. Unit of Haematology Azienda Ospedaliera Papardo Messina Italy

21. Hematology Azienda Ospedaliero‐Universitaria Senese Siena Italy

22. Hematology and Stem Cell Transplantation Unit IRCCS Centro di Riferimento Oncologico della Basilicata Rionero in Vulture Italy

23. Unit of Haematology and Stem Cell Transplantation Campus Bio‐Medico University Rome Italy

24. Department of Clinical and Molecular Medicine and Hematology Sant’Andrea – University Hospital – Sapienza University of Rome Rome Italy

25. Gruppo Amici dell'Ematologia GRADE‐Onlus Foundation Reggio Emilia Italy

26. Fondazione Italiana Linfomi Onlus Modena Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2939

Reference24 articles.

1. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

2. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

3. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

4. Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma

5. Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody based therapies in Hodgkin lymphoma;Cancer Treatment Reviews;2024-01

2. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability;Oncotarget;2023-12-12

3. Sequencing novel agents in the treatment of classical Hodgkin lymphoma;Expert Review of Hematology;2023-11-16

4. Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic;Onkologie;2023-10-05

5. Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary;Annals of Hematology;2023-07-10